Welcome!
Welcome to the North Carolina Diabetes Research Center (NCDRC), a partnership among: Duke University, North Carolina Agricultural and Technical State University, The University of North Carolina at Chapel Hill, and Wake Forest School of Medicine.
Funded in 2020 as part of the NIH/NIDDK DRC consortium, which currently consists of nine centers nationwide, the NCDRC is led by Principal Investigators Donald McClain, MD, PhD (WF), John Buse, MD, PhD (UNC), Elimelda Ongeri, PhD (NC A&T) and David D’Alessio, MD (Duke).
The theme of the NCDRC is translation.
The theme of the NCDRC is translation. We will support basic mechanistic studies, but also focus on moving preclinical to clinical studies, and engage you and your community in that process. The primary mission of the NCDRC is to provide to you, both established investigators and those new to diabetes research, with access to powerful research technologies to enhance the impact of your work, as well as to connect you with collaborators, both at intra- and inter-institutional levels, to expand the scope of your projects.
The NCDRC supports Research Cores and programs that represent unique strengths at each institution, making their expertise available to you. These currently consist of:
The Metabolomics Core, centered at Duke and offering targeted, untargeted, and flux analyses as well as interpretive services.
The Genomics and Proteomics Core, centered at Wake Forest and offering epigenomics and quantitative proteomics, as well as services such as pathway and cluster analysis.
In addition, the NCDRC offers navigation services (e.g. for access to specialized animal models and metabolic phenotyping services at all campuses) and other specialized expertise (e.g. in Advanced Clinical Studies Methods at UNC).
An enrichment program centered at NC A&T will create opportunities and provide resources for networking and advanced training/education in diabetes research. It is the aim of the NCDRC to enhance connectivity among diabetes investigators in North Carolina, and foster a wider, more vibrant community that advances basic and translational diabetes research. To this end, our first Annual Meeting will be this September 11, 2020. We hope you can join us in e-space for this virtual assembly. Registration instructions as well as the opportunity to enroll as a member of the NCDRC are provided at this website here.
A crucial aspect of the NCDRC is a Pilot and Feasibility Program that will encourage use of these new regional Cores, promote interdisciplinary research, encourage new inter- as well as intra-institution collaboration, and bring new investigators and young scientists to the diabetes field. More information about that program can also be found here.
